
Release date: 2026-03-06 16:35:31 Article From: Lucius Laos Recommended: 7
The price of osimertinib varies depending on specifications, region, purchasing channels, and medical insurance policies. For specific prices in the domestic market, it is necessary to refer to the actual selling prices at hospitals or legitimate pharmacies. This medication is a prescription drug and must be used strictly under a doctor's guidance before administration.
Osimertinib is commonly available in 80mg and 40mg specifications, with the 80mg/30-tablet pack being the mainstream specification and priced higher. Some patients may need dose adjustments, which should be determined based on the doctor's advice.
Osimertinib has been included in China's medical insurance catalog (as of 2023). Patients who meet the indications can benefit from medical insurance reimbursement, with out-of-pocket expenses varying by regional policies. In some regions, the monthly out-of-pocket cost for patients can be reduced to below a thousand yuan.
Hospital Pharmacies: Prices are lower after medical insurance reimbursement, but eligibility for medication is required.
Retail Pharmacies: Prices may be slightly higher, and it is advisable to choose qualified and legitimate pharmacies.
Overseas Purchases: Some patients opt to purchase lower-priced generic versions from abroad, but this carries legal risks and potential counterfeit drug concerns, so caution is advised.
Lucius Pharmaceuticals Osimertinib is primarily used for patients with EGFR T790M mutation-positive non-small cell lung cancer. Genetic testing is required to confirm eligibility for the medication.
Some nonprofit organizations or pharmaceutical companies provide medication assistance to financially disadvantaged patients. Patients can consult their primary physician or the hospital's social work department for more information.
Side effects such as diarrhea and skin rashes may occur during medication use. Regular follow-ups and feedback on physical condition are necessary.
Important Note: Any adjustments to medication should only be made under the guidance of a doctor. Do not purchase or change the dosage independently. If there are any questions about costs or treatment efficacy, it is recommended to seek personalized treatment plans through legitimate medical institutions.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:1532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:3942024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:1462025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:1662025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:1492025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:1772025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:1612025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:1552025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: